GOLD BOND PSORIASIS RELIEF MEDICATED MULTI-SYMPTOM- salicylic acid cream

Gold Bond Psoriasis Relief Medicated Multi-Symptom by

Drug Labeling and Warnings

Gold Bond Psoriasis Relief Medicated Multi-Symptom by is a Otc medication manufactured, distributed, or labeled by Chattem, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream

Drug Facts

Active ingredient

Salicylic acid 3%

Purposes

Psoriasis, Seborrheic Dermatitis

Uses

For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

Warnings

For external use only

Ask a doctor before use if

• condition covers a large area of the body

When using this product

• avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

• condition worsens or does not improve after regular use of this product as directed

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

Apply to affected areas one to four times daily or as directed by a doctor

Inactive ingredients

water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol

PRINCIPAL DISPLAY PANEL

Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream
Net wt 4 oz (113 g)

INGREDIENTS AND APPEARANCE

GOLD BOND PSORIASIS RELIEF MEDICATED MULTI-SYMPTOM 
salicylic acid cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 41167-0413
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
HYDROXYETHYL UREA (UNII: MBQ7DDQ7AR)
PETROLATUM (UNII: 4T6H12BN9U)
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)
GLYCERIN (UNII: PDC6A3C0OX)
DIMETHICONE (UNII: 92RU3N3Y1O)
GLUCONOLACTONE (UNII: WQ29KQ9POT)
STEARETH-21 (UNII: 53J3F32P58)
HYDROGENATED JOJOBA OIL, RANDOMIZED (UNII: Q47ST02F58)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)
SHEA BUTTER (UNII: K49155WL9Y)
METHYL GLUCETH-20 (UNII: J3QD0LD11P)
7-DEHYDROCHOLESTEROL (UNII: BK1IU07GKF)
LEVOMENOL (UNII: 24WE03BX2T)
CETEARETH-25 (UNII: 8FA93U5T67)
CORN OIL (UNII: 8470G57WFM)
GINGER (UNII: C5529G5JPQ)
CERAMIDE NP (UNII: 4370DF050B)
HYDROLYZED JOJOBA ESTERS (ACID FORM) (UNII: UDR641JW8W)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: W6000VEI5Y)
MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)
PANTHENOL (UNII: WV9CM0O67Z)
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
CERAMIDE EOS (UNII: CR0J8RN66K)
CHOLESTEROL (UNII: 97C5T2UQ7J)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
CAPROOYL PHYTOSPHINGOSINE (UNII: 2FD4Y5XL2L)
POLYSORBATE 60 (UNII: CAL22UVI4M)
CERAMIDE NS (UNII: V7M2259XJM)
CETYL ALCOHOL (UNII: 936JST6JCN)
ISOHEXADECANE (UNII: 918X1OUF1E)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
4-T-BUTYLCYCLOHEXANOL (UNII: K0H1405S9C)
CERAMIDE AP (UNII: F1X8L2B00J)
EDTA (UNII: 9G34HU7RV0)
BEHENIC ACID (UNII: H390488X0A)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
CAPROOYL SPHINGOSINE (UNII: 038753E78J)
METHYLPARABEN (UNII: A2I8C7HI9T)
TOCOPHEROL (UNII: R0ZB2556P8)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 41167-0413-2	113 g in 1 TUBE; Type 0: Not a Combination Product	08/01/2022

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M032	08/01/2022

Labeler - Chattem, Inc. (003336013)